Hyo Sup Shim

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

June, 2025

Hyo Sup Shim

May 12, 2025, 17:44 | Science

Neoadjuvant and Adjuvant Osimertinib in Stage IA to IIIA, EGFR-Mutant NSCLC

Elsevier Oncology shared a post on LinkedIn: "Advancing NSCLC Treatment: Neoadjuvant and Adjuvant Osimertinib (NORA…

Dec 29, 2024, 08:47 | Blog

Akhil Santhosh: Neoadjuvant and adjuvant osimertinib in stage IA-IIIA, EGFR-NSCLC

Akhil Santhosh, Medical Oncology Specialist at MVR Cancer Centre and Research Institute, shared a post…

Dec 25, 2024, 22:32 | Insight

Stephen Liu: Perioperative osimertinib for resectable EGFR NSCLC

Stephen Liu, Associate Professor of Medicine at Georgetown University, shared a post on X: “Perioperative…

All: 3 Posts: 1 - 100

'

BEATcc Trial at ESMOGynaec25: Atezolizumab Benefits Cervical Cancer Patients Regardless of PD-L1 Status

'

15 Posts Not to Miss from EACR 2025

'

ASCO 2025 RCC Advances: Expert Insights by Ilya Tsimafeyeu

'

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

'

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023